Using Genetic Variants to Evaluate the Causal Effect of Plasma Phospholipid Fatty Acids on Breast Cancer and Prostate Cancer: A Mendelian Randomization Study

Overview

Journal Front Genet

Date 2021 Jul 19

PMID 34276774

Citations 2

Authors

Ze Yang

Jingjia Li

Yandi Sun

Zihao Qu

Yindan Lin

Lihong Zhang

Qian He

Xueyao Jia

Mashaal Ahmad

Xueyun Zhang

Yan Luo

Affiliations

Soon will be listed here.

Abstract

Background: Observational studies indicate that phospholipid fatty acids (FAs) have an impact on the etiology in cancers, but the results are conflicting. We aimed to investigate the causal association of phospholipid FAs with breast cancer and prostate cancer.

Methods: Fourteen single nucleotide polymorphisms (SNPs) were selected as instrumental variables to predict the level of 10 phospholipid FAs from Genome-wide association studies (GWAS). We obtained the summary statistics for the latest and largest GWAS datasets for breast cancer (113,789 controls and 133,384 cases) and prostate cancer (61,106 controls and 79,148 cases) from the Breast Cancer Association Consortium (BCAC) and Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. Two-sample Mendelian randomization analysis was applied.

Results: The results demonstrate that the 10 individual plasma phospholipid FAs are not significantly associated with breast cancer risk and prostate cancer risk.

Conclusion: The evidence is insufficient to support the causal association of the 10 individual plasma phospholipid FAs with breast cancer and prostate cancer.

Citing Articles

Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.

Cui H, Zhang W, Zhang L, Qu Y, Xu Z, Tan Z PLoS Med. 2024; 21(3):e1004362.

PMID: 38489391 PMC: 10980219. DOI: 10.1371/journal.pmed.1004362.

Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer.

Deng L, Jiang A, Zeng H, Peng X, Song L Front Pharmacol. 2022; 13:947372.

PMID: 36003495 PMC: 9393251. DOI: 10.3389/fphar.2022.947372.

References

Aucoin M, Cooley K, Knee C, Fritz H, Balneaves L, Breau R . Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review. Integr Cancer Ther. 2016; 16(1):32-62. PMC: 5736071. DOI: 10.1177/1534735416656052. View

Dahm C, Gorst-Rasmussen A, Crowe F, Roswall N, Tjonneland A, Drogan D . Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2012; 96(6):1354-61. DOI: 10.3945/ajcn.112.034157. View

Manson J, Cook N, Lee I, Christen W, Bassuk S, Mora S . Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2018; 380(1):23-32. PMC: 6392053. DOI: 10.1056/NEJMoa1811403. View

Lemaitre R, Tanaka T, Tang W, Manichaikul A, Foy M, Kabagambe E . Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet. 2011; 7(7):e1002193. PMC: 3145614. DOI: 10.1371/journal.pgen.1002193. View

Alexander D, Bassett J, Weed D, Barrett E, Watson H, Harris W . Meta-Analysis of Long-Chain Omega-3 Polyunsaturated Fatty Acids (LCω-3PUFA) and Prostate Cancer. Nutr Cancer. 2015; 67(4):543-54. PMC: 4440629. DOI: 10.1080/01635581.2015.1015745. View

Bowden J, Davey Smith G, Burgess S . Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015; 44(2):512-25. PMC: 4469799. DOI: 10.1093/ije/dyv080. View

Fritsche K . The science of fatty acids and inflammation. Adv Nutr. 2015; 6(3):293S-301S. PMC: 4424767. DOI: 10.3945/an.114.006940. View

Gala H, Tomlinson I . The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitations. J Pathol. 2020; 250(5):541-554. DOI: 10.1002/path.5421. View

Zhang H, Ahearn T, Lecarpentier J, Barnes D, Beesley J, Qi G . Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020; 52(6):572-581. PMC: 7808397. DOI: 10.1038/s41588-020-0609-2. View

10.

Yuan S, Back M, Bruzelius M, Mason A, Burgess S, Larsson S . Plasma Phospholipid Fatty Acids, and Risk of 15 Cardiovascular Diseases: A Mendelian Randomisation Study. Nutrients. 2019; 11(12). PMC: 6950527. DOI: 10.3390/nu11123001. View

11.

Fabian C, Kimler B, Hursting S . Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res. 2015; 17:62. PMC: 4418048. DOI: 10.1186/s13058-015-0571-6. View

12.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

13.

Fu Y, Zheng J, Yang B, Li D . Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2015; 25(4):261-74. PMC: 4375280. DOI: 10.2188/jea.JE20140120. View

14.

Zhou Y, Wang T, Zhai S, Li W, Meng Q . Linoleic acid and breast cancer risk: a meta-analysis. Public Health Nutr. 2015; 19(8):1457-63. PMC: 10271020. DOI: 10.1017/S136898001500289X. View

15.

Brennan S, Woodside J, Lunny P, Cardwell C, Cantwell M . Dietary fat and breast cancer mortality: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2015; 57(10):1999-2008. DOI: 10.1080/10408398.2012.724481. View

16.

Yang B, Ren X, Wang Z, Wang L, Zhao F, Guo X . Biomarker of long-chain n-3 fatty acid intake and breast cancer: Accumulative evidence from an updated meta-analysis of epidemiological studies. Crit Rev Food Sci Nutr. 2018; 59(19):3152-3164. DOI: 10.1080/10408398.2018.1485133. View

17.

Lands B . Historical perspectives on the impact of n-3 and n-6 nutrients on health. Prog Lipid Res. 2014; 55:17-29. DOI: 10.1016/j.plipres.2014.04.002. View

18.

Wu J, Wilson K, Stampfer M, Willett W, Giovannucci E . A 24-year prospective study of dietary α-linolenic acid and lethal prostate cancer. Int J Cancer. 2018; 142(11):2207-2214. PMC: 5893397. DOI: 10.1002/ijc.31247. View

19.

Chajes V, Assi N, Biessy C, Ferrari P, Rinaldi S, Slimani N . A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study. Ann Oncol. 2017; 28(11):2836-2842. DOI: 10.1093/annonc/mdx482. View

20.

Simon J, Chen Y, Bent S . The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr. 2009; 89(5):1558S-1564S. DOI: 10.3945/ajcn.2009.26736E. View